2 completed, 1 recruiting, 1 withdrawn. 3 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Recruiting 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
Follow Azitra Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity ATR04-484, Vehicle - EGFR Inhibitor-associated Rash | Phase 1 / Phase 2 | Recruiting | Azitra Inc. | 32 | 2025-08-25 | 2026-10-13 |
| Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome ATR12-351 - Netherton Syndrome | Phase 1 | Completed | Azitra Inc. | 6 | 2024-06-16 | 2026-07-29 |
| Study to Evaluate the Safety of ATR-04 ATR-04, Placebo - Epidermal Growth Factor, Papulopustular Rosacea | Phase 1 / Phase 2 | Withdrawn | Azitra Inc. | 2024-01-01 | 2025-10-03 | |
| Safety Study of AZT-04 for Cosmetic Use AZT-04 - Study of Three Doses of AZT-04 for Skin Appearance | Not applicable | Completed | Azitra Inc. | 21 | 2019-01-17 | 2020-07-09 |
Ichthyosis (1) · Netherton Syndrome (1) · Rosacea (1) · Skin Diseases (1)
United States (3)